Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01895686 · ClinicalTrials.gov registry record
Comparison of Gonioscopy With Cirrus and Visante
A clinical trial, sponsored by Wills Eye.
- Completed
- Registry status
- 54
- Enrollment target
NCT01895686: Completed study, sponsored by Wills Eye.
NCT01895686 is a clinical trial that has completed, run by Wills Eye. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01895686 has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The aim of this study is to analyze similarities and evaluate interchangeability of Visante and Cirrus OCT (optical coherent tomography)and to compare agreement between gonioscopy and the two systems for evaluation of anterior segment parameters.
Primary Outcome
comparison of AS assessment by Cirrus, Visante, gonioscopies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-11 |
What the finished NCT01895686 record still lists
NCT01895686 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01895686 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01895686 about?
NCT01895686 is a clinical study titled "Comparison of Gonioscopy With Cirrus and Visante". The aim of this study is to analyze similarities and evaluate interchangeability of Visante and Cirrus OCT (optical coherent tomography)and to compare agreement between gonioscopy and the two systems for evaluation of anterior segment parameters.
What is the current status of trial NCT01895686?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2011-11. Estimated completion is 2012-11.
Who is sponsoring clinical trial NCT01895686?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia